您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Balixafortide
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Balixafortide
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CAS NO:1051366-32-5
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
POL6326
产品介绍
Balixafortide (POL6326) 是一种有效的,选择性的,耐受性好的肽类CXCR4拮抗剂,其IC50小于 10 nM。Balixafortide 对CXCR4的选择性比包括 CXCR7 在内的许多受体高出 1000 倍。Balixafortide 以 IC50< 10 nM 阻断β-arrestin募集和钙通量。Balixafortide 还是一种有效的造血干细胞和祖细胞 (HSPC) 动员剂,并具有抗癌作用。
生物活性

Balixafortide (POL6326) is a potent, selective, well-tolerated peptidicCXCR4antagonist with anIC50< 10 nM. Balixafortide shows 1000-fold selective forCXCR4than a large panel of receptors includingCXCR7. Balixafortide blocksβ-arrestinrecruitment and calcium flux with IC50s< 10 nM. Balixafortide is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2].

IC50& Target[1]

CXCR4

<10 nM (IC50)

体外研究
(In Vitro)

Balixafortide potently inhibits pERK / pAKT signaling in the lymphoma lines Namalwa (IC50< 200 nM) and Jurkat (IC50< 400 nM). Balixafortide efficiently blocks SDF-1 dependent chemotaxis of MDA MB 231 breast cancer cells (IC50< 20 nM), Namalwa and Jurkat cells (IC50< 10 nM)[1].

体内研究
(In Vivo)

Balixafortide is optimized for favorable mouse absorption, distribution, metabolism and excretion (ADME) properties with balanced plasma protein binding, greater plasma and microsomal stability[1].

Clinical Trial
分子量

1864.14

Formula

C84H118N24O21S2

CAS 号

1051366-32-5

Sequence

Cyclo(Ala-Cys-Ser-Ala-{D-Pro}-{Dab}-Arg-Tyr-Cys-Tyr-Gln-Lys-{D-Pro}-Pro-Tyr-His) (Disulfide bridge: Cys2-Cys9)

Sequence Shortening

Cyclo(ACSA-{D-Pro}-{Dab}-RYCYQK-{D-Pro}-PYH) (Disulfide bridge: Cys2-Cys9)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.